Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00407238 · ClinicalTrials.gov registry record · NA
Corneal Barrier Function With Multi-Purpose Solutions
A NA study, sponsored by Southern California College of Optometry at Marshall B. Ketchum University.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT00407238: Completed NA study, sponsored by Southern California College of Optometry at Marshall B. Ketchum University.
NCT00407238 is a NA study that has completed, run by Southern California College of Optometry at Marshall B. Ketchum University. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00407238, a NA study, has completed, sponsored by Southern California College of Optometry at Marshall B. Ketchum University.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effect on epithelial barrier function of three emarketed multi-purpose solution applied to the human eye with hydrogel lenses as during normal regimen use.
Interventions
- DEVICE Multi-purpose solutions (polyquaternium-1 and PHMB)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2006-11 |
| Est. Completion | 2007-03 |
| Phase | NA |
What the finished NCT00407238 record still lists
NCT00407238 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Multi-purpose solutions (polyquaternium-1 and PHMB) is the first listed.
NCT00407238 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00407238 about?
NCT00407238 is a clinical study titled "Corneal Barrier Function With Multi-Purpose Solutions". The purpose of this study is to evaluate the effect on epithelial barrier function of three emarketed multi-purpose solution applied to the human eye with hydrogel lenses as during normal regimen use.
What is the current status of trial NCT00407238?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2006-11. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00407238?
The interventions under investigation include: Multi-purpose solutions (polyquaternium-1 and PHMB) (DEVICE).
Who is sponsoring clinical trial NCT00407238?
This trial is sponsored by Southern California College of Optometry at Marshall B. Ketchum University, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00407238's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia